Loading...

Ctrl+K

Home
Kersti Oselin

Datreal.com

Datreal.com is an independent project that collects and publishes public data. The project is not affiliated with government institutions.
Data updated:4/23/2026•Changelog•Status

© 2026 Datreal.com

Resources

Company map
API documentation

Contact

Have suggestions or want to contribute? Write to us.

Company info in 3 seconds

Kersti Oselin — 3 companies, roles & ownership

Kersti Oselin

Active companies

3/3

Portfolio revenue

€7835

Portfolio profit

€0

Beneficial owner

Reg. Nr.: 12927110
Ownership: 100.0%
Since: 2026. gada 23. marts
Employees: 4

EESTI ONKOTERAAPIA ÜHING

Reg. Nr.: 80232894
Since: 2026. gada 23. marts
Revenue: €2000

Tallinn, Graniidi tn 12a korteriühistu

Reg. Nr.: 80384765
Since: 2026. gada 23. marts
Revenue: €5835

Appointed — Officer — Juhatuse liige
ClinVision OÜ
2026. gada 23. marts
Appointed — Officer — Juhatuse liige
EESTI ONKOTERAAPIA ÜHING
2026. gada 23. marts

Appointed — Officer — Juhatuse liige

Tallinn, Graniidi tn 12a korteriühistu

2026. gada 23. marts

Appointed — Shareholder

ClinVision OÜ

2023. gada 1. septembris

Appointed — roles.founder — Asutaja

ClinVision OÜ

2015. gada 8. oktobris

What companies does Kersti Oselin own or manage?

Kersti Oselin is linked to 3 active companies including ClinVision OÜ, EESTI ONKOTERAAPIA ÜHING, Tallinn, Graniidi tn 12a korteriühistu.

What roles does Kersti Oselin hold in business?

Kersti Oselin holds 3 officer positions, 1 roles.founder position, 1 shareholder position, 1 beneficial owner position across 3 companies.

When did Kersti Oselin first appear in the business registry?

The earliest known registry record for Kersti Oselin is from 2015-10-08, when they were registered as roles.founder at ClinVision OÜ.

What is the total revenue of Kersti Oselin's companies?

The combined revenue of Kersti Oselin's active companies is approximately €7,835, with 4 employees across all entities.

Role mix

Officer3

roles.founder1

Shareholder1

Beneficial owner1

Registry activity

Earliest8 October 2015

Latest23 March 2026